Cite Filings / ACXP
Feed Companies Filings Check
Sign in

CIK 0001736243

  • Emerging growth company

Acurx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 917-533-1469
Business address
259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
Former names
Acurx Pharmaceuticals, LLC
Filings Financials Insiders Search text
All 247 Financials 61 Shareholder Meetings 9 Executive Compensation 50 Insider Trading 59 Beneficial Ownership Interest 13 Business Combinations 39 Public Offerings 62 Mutual Funds and ETFs 6 Others 49
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-09-01
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2025-11-14
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2025-08-14
  5. DEF 14A Proxy Proxy Statement 2025-08-04
  6. DEF 14A Proxy Proxy Statement 2025-05-29
  7. DEF 14A Proxy Proxy Statement 2024-04-29
  8. SC 13G/A Stake Amended Statement of Ownership 2024-02-14
  9. DEF 14A Proxy Proxy Statement 2023-04-27
  10. SC 13G Stake Amended Statement of Ownership 2023-02-14
  11. SC 13G Stake Amended Statement of Ownership 2023-02-14
  12. DEF 14A Proxy Proxy Statement 2022-04-25
  13. SC 13D Stake ● Beneficial Ownership Report 2021-07-06
  14. SC 13D Stake ● Beneficial Ownership Report 2021-07-06

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…